drugset
drugset / Trial / NCT01661725

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001

NCT01661725 ↗

Phase 1 Completed 60 enrolled Hualan Biological Engineering, Inc.
NaSingle-groupOpen-labelPrevention

Summary

The clinical trial was designed to evaluate the safety against Group ACYW135 Meningococcal Polysaccharide Vaccine of Hualan administered on subjects 2 years of age and older.

Timeline

Start
2006-04
Primary completion
2006-04
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Group ACYW135 Meningococcal Polysaccharide Vaccine Vaccine 0.5 ml —

Indications

meningitis